Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 373,687 | 30,851 | N/A |
| Marketable Securities | 51,773 | 124,780 | N/A |
| Receivables | 386 | 81 | N/A |
| TOTAL | $432,396 | $158,693 | $N/A |
| Non-Current Assets | |||
| PPE Net | 956 | 490 | N/A |
| Other Non-Current Assets | 15,029 | 5,118 | 0 |
| TOTAL | $15,985 | $5,608 | $N/A |
| Total Assets | $448,381 | $164,301 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,908 | 3,557 | 0 |
| Accrued Expenses | 32,371 | 12,752 | N/A |
| Other current liabilities | N/A | 3,105 | N/A |
| TOTAL | $35,041 | $19,580 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 2,244 | 323,358 | 0 |
| TOTAL | $2,244 | $323,358 | $N/A |
| Total Liabilities | $37,285 | $342,938 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 80,033 | N/A | N/A |
| Common Shares | 8 | N/A | N/A |
| Retained earnings | -356,567 | -222,523 | N/A |
| Other shareholders' equity | 16 | 348 | 0 |
| TOTAL | $411,096 | $-178,637 | $N/A |
| Total Liabilities And Equity | $448,381 | $164,301 | $0 |